DHR vs KO: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and The Coca-Cola Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-17.
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
VS
The Coca-Cola Company · Consumer Defensive
$84.92
-10.2% upside to fair value
Grade C
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+7.9%).
KO trades at a lower forward P/E
(26.6x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
KO |
| Current Price |
$195.98 |
$84.92 |
| Fair Value Estimate |
$211.54 |
$76.30 |
| Upside to Fair Value |
+7.9%
|
-10.2%
|
| Market Cap |
$138.7B |
$365.4B |
| Forward P/E |
37.8x
|
26.6x
|
| EV / EBITDA |
22.8x
|
20.7x
|
| Price / Sales |
5.6x
|
7.4x
|
| Price / FCF |
26.2x
|
29.1x
|
| Revenue Growth YoY |
+3.7%
|
+12.1%
|
| Gross Margin |
60.7%
|
61.7%
|
| Operating Margin |
21.0%
|
29.3%
|
| Return on Equity |
7.1%
|
43.6%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.81%
|
3.44%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
The Coca-Cola Company is a leading global beverage company specializing in non-alcoholic drinks with a durable competitive moat driven by its strong brand and extensive distribution network. The business quality is high, evidenced by a 43.6% return on equity, robust gross margin of 61.7%, and solid revenue and earnings growth of 12.1% and 17.8% respectively in the most recent quarter. Despite the…
Accumulation Zones
| Metric |
DHR |
KO |
| Zone Low |
$158.66 |
$57.22 |
| Zone High |
$179.81 |
$64.85 |
| In Buy Zone? |
No
|
No
|